HMGCR and Cowden syndrome 1: Remarkably, all compound classes that have been already proposed for the treatment of the COVID-19 CS including corticosteroids and JAK or HMGCR inhibitors had transcriptional signatures that negatively correlated with the CSs13,15,18,38,39 (Fig. 2A and Table S7).